Meet Cory, your new AI Assistant!

Mar 18
Meet Cory, your new AI Assistant!

Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.


Now, EuroIntervention is unveiling its new AI assistant – the first of its kind in the field of academic publishing - designed to accompany readers and enhance their reading experience.


Meet Cory, the AI-powered guide that is always available to help you get to the heart of an article. 


EuroIntervention has pioneered Cory as a premium feature for subscribers, enabling you to take full advantage of this technological advance as you use the journal to enrich your daily work.

NEW ISSUE

Mar 18
Following the research – update on the latest developments, from access site closure, to valve-in-valve transcatheter aortic valve implantation, to drug-coated balloons

It seems every week there is a new trial announced or follow-up data from an ongoing one, or perhaps it is a new technique or device that you’ve heard of and are interested in checking out. You could wait for the national and international meetings. You could wait even longer for an update of one of the specialised guidelines, or you can read it here, twice a month, in our Journal – with specially chosen articles, so you can remain up to date!

Following the research – update on the latest developments, from access site closure, to valve-in-valve transcatheter aortic valve implantation, to drug-coated balloons

ORIGINAL RESEARCH

Mar 18
Bailout MANTA for transfemoral TAVI
This study evaluated the efficacy and safety of using the MANTA plug-based vascular closure device in 66 patients experiencing failed suture-based closure during transfemoral TAVI, finding it achieved haemostasis in 75.8% without complications in 86.4%.
Bailout MANTA for transfemoral TAVI

DEBATE

Mar 18
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
Margaret B. McEntegart; Victoria Delgado et al.
Two large randomized trials found no benefit of an invasive strategy guided by ischaemia and viability testing over medical therapy alone for stable CAD patients, challenging the clinical usefulness of such testing.
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
free

EDITORIAL

Mar 18
Plug-based bailout after failed suture-based large-bore vascular access closure: one more arrow in the quiver for experienced hands?
Tobias Rheude; Erion Xhepa
The ACCESS-TAVI trial randomly assigned 526 patients undergoing transfemoral TAVI to either closure of the femoral artery access site with a vascular closure device or manual compression. No significant differences were found between groups for major or minor vascular complications within 30 days.
Plug-based bailout after failed suture-based large-bore vascular access closure: one more arrow in the quiver for experienced hands?
free

AHEAD OF PRINT

Mar 5
Outcomes by sex in the ISCHEMIA trial
Mario Gaudino, Bjorn Redfors et al.

This study examined outcomes between sexes in the ISCHEMIA trial and found that women assigned to an invasive strategy were less likely to undergo revascularisation than men, but cardiovascular outcomes were similar between sexes although women had less procedural myocardial infarction.

Outcomes by sex in the ISCHEMIA trial
free

ORIGINAL RESEARCH

Mar 4
SAPT following Amplatzer LAAO
Anders Kramer, Jens Erik Nielsen-Kudsk et al.
This study evaluated the safety and efficacy of single antiplatelet therapy as the sole post-procedural antithrombotic regimen following left atrial appendage occlusion in 431 high bleeding risk patients, finding low rates of adverse events comparable to more intensive regimens.
SAPT following Amplatzer LAAO
Receive our newsletter


Comparative preclinical assessment of DCBs

EDITORIAL

Mar 18
Comparative preclinical assessment of DCBs
Michael Joner; Léa Wild
A study compared three drug-coated balloon formulations in a porcine model, assessing drug transfer and tissue distribution as surrogates for clinical efficacy. Both paclitaxel formulations showed greater smooth muscle cell loss than the sirolimus formulation, but limitations were present.
free
Subscribe banner

ORIGINAL ARTICLE

Mar 7
μQFR for functional assessment of ICAS
Kangmo Huang, Xinfeng Liu et al.
This study evaluated haemodynamic significance of intracranial atherosclerotic stenosis using quantitative flow ratio analysis in 412 patients, finding it outperformed stenosis severity in identifying culprit lesions and a nomogram integrating it and risk factors effectively stratified stroke risk.
μQFR for functional assessment of ICAS

DEBATE

Mar 4
Prophylactic stenting of vulnerable plaques: pros and cons
Duk-Woo Park, David L. Brown et al.
This study discusses preventive stenting of vulnerable plaques to reduce acute coronary syndromes risk but current imaging has limitations and stenting risks harm, requiring larger trials to prove risks and benefits.
Prophylactic stenting of vulnerable plaques: pros and cons
free

EXPERT REVIEW

Feb 19
Evolving indications for edge-to-edge repair
Mony Shuvy, Francesco Maisano

This expert review examines the use of transcatheter mitral edge-to-edge repair (TEER) in patient populations beyond current indications, discussing the outcomes and limitations seen in these diverse patient groups.

Evolving indications for edge-to-edge repair
free

RESEARCH CORRESPONDENCE

Feb 19
Final report PROTEMBO C Trial
Simone Fezzi, Darren Mylotte et al.

This study evaluated a new cerebral protection device called the ProtEmbo, which was successfully delivered and retrieved in all patients via the left radial artery. Brain MRI scans after the procedure showed a low median total volume of new lesions compared to previous studies, suggesting the device may be effective at reducing embolic strokes during transcatheter aortic valve implantation.

ORIGINAL RESEARCH

Feb 19
Outcomes of TEER for AFMR
Tetsu Tanaka, Marcel Weber et al.
This retrospective study analyzed 441 patients with functional mitral regurgitation who underwent transcatheter edge-to-edge repair. It found an association between optimal mitral regurgitation reduction, mean mitral valve pressure gradient, and clinical outcomes in patients with atrial functional mitral regurgitation.
Outcomes of TEER for AFMR

EDITORIAL

Feb 19
Between Scylla and Charybdis in Atrial Functional Mitral Regurgitation
Paolo Denti
This study discusses transcatheter edge-to-edge repair as a treatment option for mitral regurgitation in high-risk patients, especially if anatomical criteria are favorable.
free

Trending articles
243.1

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
188.65

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
169.3

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved